Decreasing exit site infections with co-trimoxazole therapy.
Leuker
K R
KR
D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
D015662:Trimethoprim, Sulfamethoxazole Drug Combination